4R‐cembranoid suppresses glial cells inflammatory phenotypes and prevents hippocampal neuronal loss in LPS‐treated mice

Abstract

AbstractChronic neuroinflammation has been implicated in neurodegenerative disease pathogenesis. A key feature of neuroinflammation is neuronal loss and glial activation, including microglia and astrocytes. 4R‐cembranoid (4R) is a natural compound that inhibits hippocampal pro‐inflammatory cytokines and increases memory function in mice. We used the lipopolysaccharide (LPS) injection model to study the effect of 4R on neuronal density and microglia and astrocyte activation. C57BL/6J wild‐type mice were injected with LPS (5 mg/kg) and 2 h later received either 4R (6 mg/kg) or vehicle. Mice were sacrificed after 72 h for analysis of brain pathology. Confocal images of brain sections immunostained for microglial, astrocyte, and neuronal markers were used to quantify cellular hippocampal phenotypes and neurons. Hippocampal lysates were used to measure the expression levels of neuronal nuclear protein (NeuN), inducible nitrous oxide synthase (iNOS), arginase‐1, thrombospondin‐1 (THBS1), glial cell‐derived neurotrophic factor (GDNF), and orosomucoid‐2 (ORM2) by western blot. iNOS and arginase‐1 are widely used protein markers of pro‐ and anti‐inflammatory microglia, respectively. GDNF promotes neuronal survival, and ORM2 and THBS1 are astrocytic proteins that regulate synaptic plasticity and inhibit microglial activation. 4R administration significantly reduced neuronal loss and the number of pro‐inflammatory microglia 72 h after LPS injection. It also decreased the expression of the pro‐inflammatory protein iNOS while increasing arginase‐1 expression, supporting its anti‐inflammatory role. The protein expression of THBS1, GDNF, and ORM2 was increased by 4R. Our data show that 4R preserves the integrity of hippocampal neurons against LPS‐induced neuroinflammation in mice.